Nexvet Biopharma PLC (NVET)

6.72
0.00 (0.00)
Prev Close 6.72
Open 6.69
Day Low/High 6.69 / 6.72
52 Wk Low/High 2.61 / 11.30
Volume 33.50K
Avg Volume 11.40K
Exchange
Shares Outstanding 12.14M
Market Cap 81.61M
EPS -1.70
Div & Yield N.A. (N.A)

Latest News

SHAREHOLDER ALERT: Brower Piven Commences An Investigation Into The Proposed Sale Of Nexvet Biopharma Plc And Encourages Investors To Contact The Firm For Additional Information

The securities litigation law firm of Brower Piven, A Professional Corporation, has commenced an investigation into possible breaches of fiduciary duty and other violations of state law by the Board of Directors of Nexvet...

SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces Filing Of A Complaint Concerning Whether The Sale Of Nexvet Biopharma Public Limited Company To Zoetis Inc. For $6.72 Per Share Is Fair To Shareholders

The following statement is being issued by Levi & Korsinsky, LLP: To: All Persons or Entities who purchased Nexvet Biopharma Public Limited Company (NASDAQ: NVET) stock  prior to April 13, 2017 .

Zoetis To Acquire Nexvet Biopharma, An Innovator In Monoclonal Antibody Therapies For Companion Animals

Zoetis Inc. (NYSE:ZTS) and Nexvet Biopharma plc (Nasdaq:NVET) today announced an agreement in which Zoetis, through a wholly owned subsidiary ("Zoetis Bidco"), will purchase Nexvet, an innovator in monoclonal...

Nexvet Announces Positive Results From NV-02 Pilot Field Study In Cats With Osteoarthritis

Nexvet Announces Positive Results From NV-02 Pilot Field Study In Cats With Osteoarthritis

NV-02 Pivotal Study Plans Underway